Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs

Int J Pharm. 2008 Jun 24;358(1-2):292-5. doi: 10.1016/j.ijpharm.2008.02.005. Epub 2008 Feb 15.

Abstract

The aim of this work was to evaluate the potentiality to control the drug release of a new architecture of microparticles organized at the nanoscopic scale by assembling polymeric nanocapsules at the surface of drug-loaded xerogels. Xerogel was prepared by sol-gel method using sodium diclofenac, as hydrophilic drug model, and coated by spray-drying. After coating, the surface areas decreased from 82 to 28 m(2)/g, the encapsulation efficiency was 71% and SEM analysis showed irregular microparticles coated by the nanocapsules. Formulation showed satisfactory gastro-resistance presenting drug release lower than 3% (60 min) in acid medium. In water, the pure drug dissolved 92% after 5 min, uncoated drug-loaded xerogel released 60% and nanocapsule coated drug-loaded xerogel 36%. After 60 min, uncoated drug-loaded xerogel released 82% and nanocapsule coated drug-loaded xerogel 62%. In conclusion, the new system was able to control the release of the hydrophilic drug model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Chromones
  • Delayed-Action Preparations
  • Desiccation
  • Diclofenac / administration & dosage*
  • Drug Compounding
  • Drug Delivery Systems
  • Microscopy, Electron, Scanning
  • Nanoparticles
  • Nitrogen
  • Polymethacrylic Acids
  • Surface Properties

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Chromones
  • Delayed-Action Preparations
  • Polymethacrylic Acids
  • Diclofenac
  • methylmethacrylate-methacrylic acid copolymer
  • tricetin
  • Nitrogen